Jane Street
URGN icon

Jane Street’s UroGen Pharma URGN Stock Holding History

Jane Street’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$350K Buy
+9,505
New +$258K ﹤0.01% 8862
2025
Q4 		– Sell
-328,419
Closed -$7.12M – 12449
2025
Q3 		$6.55M Buy
328,419
+181,139
+123% +$3.25M ﹤0.01% 3007
2025
Q2 		$2.02M Buy
147,280
+96,103
+188% +$922K ﹤0.01% 4397
2025
Q1 		$566K Buy
51,177
+24,839
+94% +$265K ﹤0.01% 6633
2024
Q4 		$280K Sell
26,338
-4,380
-14% -$52.4K ﹤0.01% 7846
2024
Q3 		$390K Sell
30,718
-29,598
-49% -$439K ﹤0.01% 7609
2024
Q2 		$1.01M Buy
60,316
+37,899
+169% +$539K ﹤0.01% 5746
2024
Q1 		$336K Buy
22,417
+5,808
+35% +$94.9K ﹤0.01% 7373
2023
Q4 		$249K Buy
16,609
+6,552
+65% +$85.1K ﹤0.01% 7901
2023
Q3 		$141K Sell
10,057
-3,298
-25% -$52.9K ﹤0.01% 7814
2023
Q2 		$138K Sell
13,355
-71,515
-84% -$789K ﹤0.01% 7851
2023
Q1 		$784K Buy
+84,870
New +$781K ﹤0.01% 5483
2020
Q4 		– Sell
-21,738
Closed -$419K – 8137
2020
Q3 		$419K Sell
21,738
-528
-2% -$12K ﹤0.01% 5422
2020
Q2 		$582K Buy
22,266
+7,797
+54% +$191K ﹤0.01% 4836
2020
Q1 		$258K Sell
14,469
-17,250
-54% -$466K ﹤0.01% 4379
2019
Q4 		$1.06M Buy
+31,719
New +$866K ﹤0.01% 2707
2018
Q3 		– Sell
-4,563
Closed -$227K – 5731
2018
Q2 		$227K Buy
+4,563
New +$266K ﹤0.01% 4429

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Jane Street's URGN Position: Q2 2026 in Review

Jane Street opened a new position in UroGen Pharma (URGN) in Q2 2026: 9,505 shares worth $350K. The stake represents ﹤0.01% of the portfolio and ranks #8862 among its holdings. This is a return to the name: Jane Street previously reported a position in URGN as recently as Q3 2025.

Jane Street first reported a position in URGN in Q2 2018 and has held it in 17 quarters since. The position peaked at $6.55M in Q3 2025. 189 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • Jane Street held 9,505 shares of UroGen Pharma worth $350K as of Q2 2026.
  • UroGen Pharma was a new Jane Street position in Q2 2026.
  • UroGen Pharma made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8862 holding.
  • Jane Street first reported a position in UroGen Pharma in Q2 2018 and has held it in 17 quarters since.
  • Jane Street's UroGen Pharma position peaked at $6.55M in Q3 2025.
  • 189 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.